Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements
View Patent ↗The present invention relates generally to methods and compositions for identifying morphogenic protein analogs. In one embodiment, this invention relates to an osteogenic protein reponsive transcription inhibitory element. This invention also relates to the identified morphogenic protein analogs which can mimic the biological effects of morphogenic proteins, particularly those relating to the BMP family such as osteogenic protein (OP-1), on the regulation of gene expression and tissue inductive capabilities.
1. An isolated DNA sequence comprising a morphogenic protein responsive transcription inhibitory element operably linked to a reporter gene encoding a detectable product, wherein the morphogenic protein responsive transcription inhibitory element consists of nucleotides 817-837 of SEQ ID NO. 1.
2. An isolated DNA sequence comprising a morphogenic protein responsive transcription inhibitory element operably linked to a reporter gene encoding a detectable product, wherein the morphogenic protein responsive transcription inhibitory element consists of nucleotides 807-847 of SEQ ID NO. 1.
3. An isolated DNA sequence comprising a morphogenic protein responsive transcription inhibitory element operably linked to a reporter gene encoding a detectable product, wherein the morphogenic protein responsive transcription inhibitory element consists of nucleotides 799-857 of SEQ ID NO. 1.
4. The DNA sequence according to any one of claims 1 - 3 wherein the detectable product is luciferase or chloramphenicol acetyl transferase.
5. A vector comprising the DNA sequence according to any one of claims 1 - 3 .
6. A cell transfected with the DNA sequence of any one of claims 1 - 3 .
7. The isolated DNA sequence according to any one of claims 1 - 3 , wherein the morphogenic protein responsive transcription inhibitory element is an OP-1 responsive transcription inhibitory element.
8. The vector according to claim 5 , wherein the morphogenic protein responsive transcription inhibitory element is an OP-1 responsive transcription inhibitory element.
9. The cell according to claim 6 , wherein the morphogenic protein responsive transcription inhibitory element is an OP-1 responsive transcription inhibitory element.
10. A vector comprising the DNA sequence according to claim 4 .
11. A cell transfected with the DNA sequence according to claim 4 .
12. The vector according to claim 10 , wherein the morphogenic protein responsive transcription inhibitory element in an OP-1 responsive transcription inhibitory element.
13. The vector according to claim 11 , wherein the morphogenic protein responsive transcription inhibitory element in an OP-1 responsive transcription inhibitory element.